Dietary Supplement
PB-125
PB-125 is a dietary supplement with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
1(33%)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 2 finished
Non-Completion Rate
100.0%
2 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Terminated(2)
Detailed Status
Active, not recruiting1
Terminated1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
active_not_recruiting133%
terminated133%
withdrawn133%
Recent Activity
1 active trials
Showing 3 of 3
active_not_recruitingnot_applicable
Targeting Oxidative Stress to Prevent Vascular and Skeletal Muscle Dysfunction During Disuse
NCT04351113
withdrawnnot_applicable
Improving Exercise Rehabilitation Efficacy Outcomes Veterans Peripheral Artery Disease
NCT05648630
terminatednot_applicable
PB125, Osteoarthritis, Pain, Mobility, and Energetics
NCT04638387
Clinical Trials (3)
Showing 3 of 3 trials
NCT04351113Not Applicable
Targeting Oxidative Stress to Prevent Vascular and Skeletal Muscle Dysfunction During Disuse
NCT05648630Not Applicable
Improving Exercise Rehabilitation Efficacy Outcomes Veterans Peripheral Artery Disease
NCT04638387Not Applicable
PB125, Osteoarthritis, Pain, Mobility, and Energetics
All 3 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 3